Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease-Reference-Cited by-同舟云学术

Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease

Published:2023-10-16 Issue:11 Volume:8 Page:2033-2049
ISSN:2058-5276
Container-title:Nature Microbiology
language:en
Short-container-title:Nat Microbiol

Author:

Odenwald Matthew A.^ORCID,Lin Huaiying,Lehmann Christopher^ORCID,Dylla Nicholas P.^ORCID,Cole Cody G.^ORCID,Mostad Jake D.,Pappas Téa E.^ORCID,Ramaswamy Ramanujam^ORCID,Moran Angelica^ORCID,Hutchison Alan L.^ORCID,Stutz Matthew R.,Dela Cruz Mark,Adler Emerald,Boissiere Jaye,Khalid Maryam,Cantoral Jackelyn,Haro Fidel,Oliveira Rita A.^ORCID,Waligurski Emily^ORCID,Cotter Thomas G.,Light Samuel H.^ORCID,Beavis Kathleen G.,Sundararajan Anitha,Sidebottom Ashley M.^ORCID,Reddy K. Gautham,Paul Sonali,Pillai Anjana,Te Helen S.,Rinella Mary E.^ORCID,Charlton Michael R.,Pamer Eric G.^ORCID,Aronsohn Andrew I.

Funder

U.S. Department of Health & Human Services | National Institutes of Health

U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health

Searle Scholars Program

Duchossois Family Institute

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Microbiology (medical),Genetics,Applied Microbiology and Biotechnology,Immunology,Microbiology

Link

https://www.nature.com/articles/s41564-023-01493-w.pdf

Reference95 articles.